Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| 89R13930 AND-D | ||
| By: Menéndez | S.B. No. 2470 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to the requirements for the labeling and dispensing of a | |
| prescription drug or biological product. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Section 562.006, Occupations Code, is amended by | |
| amending Subsections (b) and (f) and adding Subsection (g) to read | |
| as follows: | |
| (b) In addition to the information required by Subsection | |
| (a), the label on the dispensing container of a drug or biological | |
| product dispensed by a Class A or Class E pharmacy must [ |
|
| (1) indicate: | |
| (A) the name, address, and telephone number of | |
| the pharmacy; | |
| (B) [ |
|
| dispensed; | |
| (C) [ |
|
| practitioner; | |
| (D) [ |
|
| or biological product was prescribed for an animal, the species of | |
| the animal and the name of the owner; | |
| (E) [ |
|
| (F) [ |
|
| (G) [ |
|
| dispensed in a container other than the manufacturer's original | |
| container, the date after which the prescription should not be | |
| used, determined according to criteria established by board rule | |
| based on standards in the United States Pharmacopeia-National | |
| Formulary; and | |
| (H) [ |
|
| board rule; and | |
| (2) include, in a format accessible to the patient | |
| through a mobile Internet application or assistive technology | |
| electronic device available to the patient at no cost, the | |
| information described by Subdivision (1) and information regarding | |
| potential side effects and contraindicated medications. | |
| (f) The [ |
|
| dispensing container must [ |
|
| Times New Roman with a minimum of 12-point [ |
|
| size [ |
|
| (g) A pharmacist at a Class A or Class E pharmacy shall, on a | |
| patient's request, provide to the patient a large-print data sheet | |
| containing: | |
| (1) the information required under Subsection (b)(1) | |
| to be on the label on a dispensing container of a drug or biological | |
| product dispensed to the patient; and | |
| (2) information regarding potential side effects and | |
| contraindicated medications for the drug or biological product | |
| dispensed to the patient. | |
| SECTION 2. Not later than January 1, 2026, the Texas State | |
| Board of Pharmacy shall adopt any rules necessary to implement the | |
| changes in law made by this Act. | |
| SECTION 3. The changes in law made by this Act apply only to | |
| a drug or biological product dispensed on or after March 1, 2026. A | |
| drug or biological product dispensed before March 1, 2026, is | |
| governed by the law in effect immediately before the effective date | |
| of this Act, and the former law is continued in effect for that | |
| purpose. | |
| SECTION 4. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.